Request Demo
Last update 20 Mar 2025
Interferon gamma (Nostrum)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Interferons |
Synonyms- |
Target |
Action stimulants |
Mechanism IFNGR stimulants(Interferon gamma receptor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Interferon gamma (Nostrum)ChiCTR1900025247
Phase II clinical study for efficacy and safety of interferon gamma combined with docetaxel, carboplatin and trastuzumab in neoadjuvant treatment of HER-2 positive breast cancer
ISRCTN72024361
Randomised controlled trial of short course adjunctive interferon gamma for inital treatment of human immunodeficiency virus (HIV)-associated cryptococcal meningitis: effect on rate of clearance of infection and immune response
100 Clinical Results associated with Interferon gamma (Nostrum)
Login to view more data
100 Translational Medicine associated with Interferon gamma (Nostrum)
Login to view more data
100 Patents (Medical) associated with Interferon gamma (Nostrum)
Login to view more data
1
Literatures (Medical) associated with Interferon gamma (Nostrum)01 Apr 1990Gynecologic OncologyQ2 · MEDICINE
Interferon γ treatment for cervical intraepithelial neoplasia
Q2 · MEDICINE
Article
Author: Toru Hachisuga ; Yoshinobu Hayashi ; Hajime Sugimori ; Masatoshi Yokoyama ; Tsuyoshi Iwasaka
100 Deals associated with Interferon gamma (Nostrum)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Phase 2 | - | - | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | - | - | |
| Pulmonary Fibrosis | Phase 2 | - | - | |
| Pulmonary Fibrosis | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | (High INFG expression) | (iussxsbbkx) = gpiytvxqcy ljgkxsewcq (qbbrfpspfx ) View more | Positive | 30 May 2017 | ||
(Low INFG expression) | (iussxsbbkx) = ntbkctujze ljgkxsewcq (qbbrfpspfx ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free